• Western blot analysis of lysates from SW480 cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-TRIM58 antibody (355-405 aa) (STJ195369)

SKU:
STJ195369

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-E3 ubiquitin-protein ligase TRIM58 (355-405 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: TRIM58
Gene ID: 25893
Uniprot ID: TRI58_HUMAN
Immunogen Region: 355-405 aa
Specificity: This antibody detects endogenous levels of TRI58 at Human/Mouse
Immunogen: Synthesized peptide derived from the human TRI58 at the amino acid range 355-405
Function E3 ubiquitin ligase induced during late erythropoiesis. Directly binds and ubiquitinates the intermediate chain of the microtubule motor dynein (DYNC1LI1/DYNC1LI2), stimulating the degradation of the dynein holoprotein complex. May participate in the erythroblast enucleation process through regulation of nuclear polarization.
Protein Name E3 Ubiquitin-Protein Ligase Trim58
Protein Bia2
Ring-Type E3 Ubiquitin Transferase Trim58
Tripartite Motif-Containing Protein 58
Alternative Antibody Names Anti-E3 Ubiquitin-Protein Ligase Trim58 antibody
Anti-Protein Bia2 antibody
Anti-Ring-Type E3 Ubiquitin Transferase Trim58 antibody
Anti-Tripartite Motif-Containing Protein 58 antibody
Anti-TRIM58 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance